Literature DB >> 25199063

Brain PET in the diagnosis of Alzheimer's disease.

Charles Marcus1, Esther Mena, Rathan M Subramaniam.   

Abstract

OBJECTIVES: The aim of this article was to review the current role of brain PET in the diagnosis of Alzheimer dementia. The characteristic patterns of glucose metabolism on brain FDG-PET can help in differentiating Alzheimer's disease from other causes of dementia such as frontotemporal dementia and dementia of Lewy body. Amyloid brain PET may exclude significant amyloid deposition and thus Alzheimer's disease in appropriate clinical setting.
CONCLUSIONS: FDG-PET and amyloid PET imaging are valuable in the assessment of patients with Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25199063      PMCID: PMC4332800          DOI: 10.1097/RLU.0000000000000547

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  73 in total

1.  2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6- (2-[fluoro]ethoxy)benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients.

Authors:  Yukitsuka Kudo; Nobuyuki Okamura; Shozo Furumoto; Manabu Tashiro; Katsutoshi Furukawa; Masahiro Maruyama; Masatoshi Itoh; Ren Iwata; Kazuhiko Yanai; Hiroyuki Arai
Journal:  J Nucl Med       Date:  2007-04       Impact factor: 10.057

2.  Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease.

Authors:  Victor L Villemagne; Kerryn E Pike; Gaël Chételat; Kathryn A Ellis; Rachel S Mulligan; Pierrick Bourgeat; Uwe Ackermann; Gareth Jones; Cassandra Szoeke; Olivier Salvado; Ralph Martins; Graeme O'Keefe; Chester A Mathis; William E Klunk; David Ames; Colin L Masters; Christopher C Rowe
Journal:  Ann Neurol       Date:  2011-01       Impact factor: 10.422

3.  F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Abeta aggregates in the brain.

Authors:  Wei Zhang; Shunichi Oya; Mei-Ping Kung; Catherine Hou; Donna L Maier; Hank F Kung
Journal:  Nucl Med Biol       Date:  2005-11       Impact factor: 2.408

4.  FDG PET imaging in patients with pathologically verified dementia.

Authors:  J M Hoffman; K A Welsh-Bohmer; M Hanson; B Crain; C Hulette; N Earl; R E Coleman
Journal:  J Nucl Med       Date:  2000-11       Impact factor: 10.057

5.  Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing.

Authors:  Sid Gilman; Robert A Koeppe; Roderick Little; Hyonggin An; Larry Junck; Bruno Giordani; Carol Persad; Mary Heumann; Kris Wernette
Journal:  Exp Neurol       Date:  2005-02       Impact factor: 5.330

Review 6.  PET/CT of cancer patients: part 1, pancreatic neoplasms.

Authors:  Elizabeth H Dibble; Dimitrios Karantanis; Gustavo Mercier; Patrick J Peller; Lisa A Kachnic; Rathan M Subramaniam
Journal:  AJR Am J Roentgenol       Date:  2012-11       Impact factor: 3.959

7.  Effects of human aging on patterns of local cerebral glucose utilization determined by the [18F]fluorodeoxyglucose method.

Authors:  D E Kuhl; E J Metter; W H Riege; M E Phelps
Journal:  J Cereb Blood Flow Metab       Date:  1982       Impact factor: 6.200

8.  Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.

Authors:  Kerryn E Pike; Greg Savage; Victor L Villemagne; Steven Ng; Simon A Moss; Paul Maruff; Chester A Mathis; William E Klunk; Colin L Masters; Christopher C Rowe
Journal:  Brain       Date:  2007-10-10       Impact factor: 13.501

9.  FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease.

Authors:  Norman L Foster; Judith L Heidebrink; Christopher M Clark; William J Jagust; Steven E Arnold; Nancy R Barbas; Charles S DeCarli; R Scott Turner; Robert A Koeppe; Roger Higdon; Satoshi Minoshima
Journal:  Brain       Date:  2007-08-18       Impact factor: 13.501

Review 10.  Disease-modifying drugs in Alzheimer's disease.

Authors:  Laura Ghezzi; Elio Scarpini; Daniela Galimberti
Journal:  Drug Des Devel Ther       Date:  2013-12-06       Impact factor: 4.162

View more
  68 in total

1.  Metabolic profiling reveals biochemical pathways and potential biomarkers associated with the pathogenesis of Krabbe disease.

Authors:  Nadav I Weinstock; Lawrence Wrabetz; M Laura Feltri; Daesung Shin
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

2.  Classification of MRI and psychological testing data based on support vector machine.

Authors:  Wenlu Yang; Xinyun Chen; David S Cohen; Eric R Rosin; Arthur W Toga; Paul M Thompson; Xudong Huang
Journal:  Int J Clin Exp Med       Date:  2017-12

3.  Enhancement of Partial Volume Correction in MR-Guided PET Image Reconstruction by Using MRI Voxel Sizes.

Authors:  Martin A Belzunce; Abolfazl Mehranian; Andrew J Reader
Journal:  IEEE Trans Radiat Plasma Med Sci       Date:  2018-11-15

4.  A high resolution and high detection efficiency depth-encoding detector for brain positron emission tomography based on a 0.75 mm pitch scintillator array.

Authors:  J Du; S R Cherry
Journal:  J Instrum       Date:  2021-05-20       Impact factor: 1.415

5.  Near-infrared spectroscopy (NIRS) and vagus somatosensory evoked potentials (VSEP) in the early diagnosis of Alzheimer's disease: rationale, design, methods, and first baseline data of the Vogel study.

Authors:  Thomas Polak; Martin J Herrmann; Laura D Müller; Julia B M Zeller; Andrea Katzorke; Matthias Fischer; Fabian Spielmann; Erik Weinmann; Leif Hommers; Martin Lauer; Andreas J Fallgatter; Jürgen Deckert
Journal:  J Neural Transm (Vienna)       Date:  2017-09-01       Impact factor: 3.575

6.  Visual memory tests enhance the identification of amnestic MCI cases at greater risk of Alzheimer's disease.

Authors:  Javier Oltra-Cucarella; Miriam Sánchez-SanSegundo; Darren M Lipnicki; John D Crawford; Richard B Lipton; Mindy J Katz; Andrea R Zammit; Nikolaos Scarmeas; Efthimios Dardiotis; Mary H Kosmidis; Antonio Guaita; Roberta Vaccaro; Ki Woong Kim; Ji Won Han; Nicole A Kochan; Henry Brodaty; José A Pérez-Vicente; Luis Cabello-Rodríguez; Perminder S Sachdev; Rosario Ferrer-Cascales
Journal:  Int Psychogeriatr       Date:  2018-10-25       Impact factor: 3.878

7.  FDG-PET patterns associated with underlying pathology in corticobasal syndrome.

Authors:  Matteo Pardini; Edward D Huey; Salvatore Spina; William C Kreisl; Silvia Morbelli; Eric M Wassermann; Flavio Nobili; Bernardino Ghetti; Jordan Grafman
Journal:  Neurology       Date:  2019-01-30       Impact factor: 9.910

8.  MWPCR: Multiscale Weighted Principal Component Regression for High-dimensional Prediction.

Authors:  Hongtu Zhu; Dan Shen; Xuewei Peng; Leo Yufeng Liu
Journal:  J Am Stat Assoc       Date:  2016-12-16       Impact factor: 5.033

9.  In Vivo Imaging of the Tumor-Associated Enzyme NCEH1 with a Covalent PET Probe.

Authors:  Jae Won Chang; Mohammed Bhuiyan; Hsiu-Ming Tsai; Hannah J Zhang; Gang Li; Shaghayegh Fathi; David C McCutcheon; Lara Leoni; Richard Freifelder; Chin-Tu Chen; Raymond E Moellering
Journal:  Angew Chem Int Ed Engl       Date:  2020-06-15       Impact factor: 15.336

10.  A layered single-side readout depth of interaction time-of-flight-PET detector.

Authors:  L Bläckberg; S Sajedi; G El Fakhri; H Sabet
Journal:  Phys Med Biol       Date:  2021-02-11       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.